Multiple sclerosis--the plaque and its pathogen... [N Engl J Med. 2006] - PubMed

loading

The pathogenesis and basis for treatment in multiple sclerosis. [Clin Neurol Neurosurg. 2004]
The pathogenesis and basis for treatment in multiple sclerosis.
Compston A. Clin Neurol Neurosurg. 2004 Jun; 106(3):246-8.
Review The neuropathology of multiple sclerosis. [Neuroimaging Clin N Am. 2000]
Review The neuropathology of multiple sclerosis.
Ludwin SK. Neuroimaging Clin N Am. 2000 Nov; 10(4):625-48 ,vii.
Neuronal degeneration in a viral model of multiple sclerosis. [J Neurosci. 2009]
Neuronal degeneration in a viral model of multiple sclerosis.
Schneider R. J Neurosci. 2009 Dec 9; 29(49):15353-4.
Review Multiple sclerosis - candidate mechanisms underlying CNS atrophy. [Trends Neurosci. 2010]
Review Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. Trends Neurosci. 2010 Apr; 33(4):202-10. Epub 2010 Feb 12.
Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. [Ann Neurol. 1994]
Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.
Lassmann H, Suchanek G, Ozawa K. Ann Neurol. 1994; 36 Suppl:S42-6.

Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS. [Sci Rep. 2013]
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.
Duan H, Xing S, Luo Y, Feng L, Gramaglia I, Zhang Y, Lu D, Zeng Q, Fan K, Feng J, et al. Sci Rep. 2013 Apr 18; 3:1687.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. [PLoS One. 2013]
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, Schmalbrock P, Pitt D. PLoS One. 2013; 8(3):e57573. Epub 2013 Mar 14.
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod. [Ther Clin Risk Manag. 2013]
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.
Gasperini C, Ruggieri S, Mancinelli CR, Pozzilli C. Ther Clin Risk Manag. 2013; 9:73-85. Epub 2013 Mar 3.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Multiple sclerosis--the plaque and its pathogenesis.
Multiple sclerosis--the plaque and its pathogenesis.
N Engl J Med. 2006 Mar 2 ;354(9):942-55.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed